WHO Framework Convention on Tobacco ControlWHOFCTC IT A 1106 Circulation Journal Vol. 69, Suppl. IV, 2005



Similar documents

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

終末期の呼吸困難症状への対応*松坂最終修正

食道がん化学放射線療法後のsalvage手術


日医総研ワーキングペーパー

生命倫理_Vol.25_No.1

本文.indd

2009年133巻3号3月号.indb

慢性膵炎

Rinku General Medical Center

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

Unknown

GB 3rd edition final.ppt

診療ガイドラインのカラクリ

21-07_後藤論文.smd

untitled

.K.C.h...C...ren

ICT 1 21 ICT., Cooper, Dawson

_’£”R‡Ù‡©

日本皮膚科学会雑誌第121巻第12号

00.\...ec5


C/NC : committed/noncommitted

untitled

et al No To Shinkei Clin Neurol Neurology et al J Neurosurg et al Arch Neurol et al Angiology

untitled


東洋医学雑誌

表 参照文献 ( 文献 ). 185, Expert Nurse. 1211, suppl, , CNS 2000, , , , 4

平成14年8月22日

好酸球性副鼻腔炎:診断ガイドライン(JESREC Study)

越智59.qxd

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

動くレントゲン

untitled

日本臨床麻酔学会 vol.30

肺癌第49巻第1号


MV X 5 6 Common Terminology Criteria for Adverse Events Grade 1 Grade Gy 16 QOL QOL 5 6 7, 8 9, VOL.3 NO

国内雑誌利用統計 ~ 詳細版 ~ 2017 年の利用統計は 1 月から 7 月までを集計しています Medical Finder の 2016 年利用統計は 11 月から 12 月までを集計しています 利用件数利用順位契約状況 No. メディカル Medical オンライン Finder 1 医学の

36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

A C A0 B C 1250 Circulation Journal Vol. 66, Suppl. IV, 2002

...A

前頭蓋底の再建術式の標準化と外傷への応用

4 たばこ分科会報告 (案)

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio


慈大呼吸器_25-1_02T_CS5.indd

untitled

EMS EMS W264

スライド 1

<30332D D8CB492982D FC95E490E690B62D8FAC8FBC96BE90E690B62E706466>

不安障害研究, 9(1), 17-32, 2017

Vol. No. Honda, et al.,

a naturalistic b Midgley, N., 2011 Child Psychotherapy and Research - New Approaches, Emerging Findings Catty, J., 2011 Catty, 2011 b Catty 2011 Wren,

1_2.eps

.k....-._.C.W.F.X.g01-01

Juntendo Medical Journal

untitled

VOL.42 S-1

164 SDD & SOD SDD E100 mg 80 mg B500 mg 2 E 2 B 48 /59 81 SDD SOD 10 /63 16 RCT RCT 1992 Gastinne 15 ICU 445 SDD E100 mg 80 mg B 10

Core Ethics Vol. : - NICU : : - A B C D

Title 泌尿器科領域に於ける17-Ketosteroidの研究 17-Ketosteroidの臨床的研究 第 III 篇 : 尿 Author(s) 卜部, 敏入 Citation 泌尿器科紀要 (1958), 4(1): 3-31 Issue Date URL

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 2 Apr NTT NTT

13●53頁●6-7▲院内感染対策▲.ppt


198 Table 1a Preoperative patients characteristics (EVH group) Age (y.o) Gender Comorbidity Lesion TASC II Fontaine 51 male HTN, HPL, DM, smoking Lt S

2

発行日 : オンラインジャーナル利用統計 (2018 年 1 月 ~7 月 )~ 上位ランキング ~ 国内雑誌 順位雑誌名件数順位雑誌名件数 1 総合診療 ( 前誌 :JIM) New England Journal of Medicine 年連続 No.1

医療事故の現状と課題-医療事故への対応策の整備を中心に-

立命館

整形外科病棟における高齢者の術後せん妄予防に関する考察 1 総説 (2013 年 12 月 25 日受稿 ) 抄録 CNS PT OT QOL Ⅰ. 緒言 北海道文教大学人間科学部看護学科

老年医学update

Nutrition-vol.2-表紙a

小児感染免疫第23巻第1号

Healthcare_Errorproofing.PDF

The Heart Healthy Tocotrienol Complex Tocomin SupraBio

表紙

クローン

審査報告書(案)

CQ 1,.,,.,,...,,,,,,.,,,,,,,MAO 2., 24,. A




2010 年 6 月 25 表 身体所見 134 cm 31 kg /60 mmhg 83/ ,


Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo


日本皮膚科学会雑誌第122巻第2号

1 見出し1,12ポ,日本語ゴシック,英語Arial,段落後は6ポの設定です

1. はじめに麻酔科医は喫煙習慣のある患者において呼吸 循環機能をはじめとして様々な内容で周術期管理に苦慮することを経験してきた 日本麻酔科学会は 2008 年 6 月に 禁煙宣言 を行ったが 現実的には麻酔科医の関心は薄く充分な成果をあげているとは言い難い 喫煙が周術期の全身管理に影響を与え 予後

01 Total assist Total assist 02

橡

+深見将志.indd

橡96-07.PDF

PubMed 1. CD-ROM MEDLINE MeSH PubMed 2. Automatic Term Mapping MeSH 3. Related Article MeSH Browser MeSH PreMEDLINE MeSH -2-

No I ( ) 7 II ( ) Material Database ( ) I 34 2 II 35 3 III

Transcription:

20032004 Smoking Cessation Guideline (JCS 2005) 50 1 1 2 3 4 5 2 1 2 3 4 5 6 3 Circulation Journal Vol. 69, Suppl. IV, 2005 1105

20032004 1 2003 5 WHO Framework Convention on Tobacco ControlWHOFCTC 1 2 3 IT 2000 1 A 1106 Circulation Journal Vol. 69, Suppl. IV, 2005

B C 2 3 1 A 2 5A AskAdviseAssess AssistArrange 1 1 1Ask A1 23 4 4 1 5A 2Advise A 3Assess C 5 R 1 5 R RelevanceRisksRewards RoadblocksRepetition CO 2 5A 4Assist 1 2 2 A 3 A 5Arrange C 3 3 C 4 Circulation Journal Vol. 69, Suppl. IV, 2005 1107

20032004 1 5 1Ask 2Advise 3Assess 4Assist 5Arrange 30 2 1 1 SR 1 2 1 2 1 1108 Circulation Journal Vol. 69, Suppl. IV, 2005

3 11 A 2 A 3 A 4 A 5 B B 1 A 1 2 1 3 A R OTC R TTS 3 2 SR 1 A 2 4 4 1 Circulation Journal Vol. 69, Suppl. IV, 2005 1109

20032004 2 2 1015 6 10 2 4 1 3 1 0.8 1 1 12 1 4 2005 2 27 1110 Circulation Journal Vol. 69, Suppl. IV, 2005

4 4 1 5 1 6 100 2 3 2002 25 2003 5 Circulation Journal Vol. 69, Suppl. IV, 2005 1111

20032004 1 0 1 2 3 4 5 6 7 8 7.56 2.76 2.76 2.63 2.56 2.37 2.18 1.94 1.93 1.79 1.66 1.63 20 3.27 4.46 4.30 4.02 3.97 3.88 3.80 3.77 3.64 3.53 6.33 Non-Smokers' Rights Association, Canada2002 6 17 5 20 2002 5 31 US 4 2003 11 2005 7 1 30 % 100 % 7 5 1900 1112 Circulation Journal Vol. 69, Suppl. IV, 2005

5 8 212 259 696 873 6 4,000 13,000 800 1999 NHSNational Health Service 5 8 9 5 % 25 2 20 15 10 5 0 2004 1991 2001 1996 1996 2000 1011 Circulation Journal Vol. 69, Suppl. IV, 2005 1113

20032004 1 1 2004 10 11 22001 2 2 1 12 Version. 5.02005 7 2 3 25 1 1 1 EBM 1114 Circulation Journal Vol. 69, Suppl. IV, 2005

2 A2 CO Ca 2 5 3 1 1 2 2 3 4 1 3 PASSPORT TO STOP SMOKING 2DVD. 2001 Circulation Journal Vol. 69, Suppl. IV, 2005 1115

20032004 AHA 2002 4 2002 4 3 10 2 1 6 6 1 2COPD 3 4 5 1 2 3respiratory bronchiolitis-associated interstitial lung diseaserbild 6 7 8 9 13 Chronic Obstructive Pulmonary Disease; COPD 10 1 COPD GOLD COPD COPD 8090 % COPD 1520 % 2 COPD 10 3050 % COPD 3 COPD 1 7 1116 Circulation Journal Vol. 69, Suppl. IV, 2005

7 4 COPD 1997 2003 3 43 1 1 1 2 3 4 2 1 1 2 3 2 1 2 3 4 3 1 CO 2 3 4 3 14 15 40 40 30 20 2 3 1 2 Circulation Journal Vol. 69, Suppl. IV, 2005 1117

20032004 3 4 COPD 5 12 4 2 NRT 4 1 3 1 16 1118 Circulation Journal Vol. 69, Suppl. IV, 2005

2 1 17 2 1 2 714 3 1 1 12 3 1 3 12 12 3 18 5 1 Circulation Journal Vol. 69, Suppl. IV, 2005 1119

20032004 2004 19 2 Betel quid areca nutbetel leafslaked lime tobacco areca nut arecoline N-nitro samines DNA Slaked lime DNA LeukoplakiaVerrucous tumor Cancer Anemic changessubmucus fibrosis 30 % 19 3 8 8 1 65,073 1,265 2002 1 115 17 % 1999 5 74 40 2001 1 1 80 4 1996 2005 2001 1120 Circulation Journal Vol. 69, Suppl. IV, 2005

6 1 COHb CO CO 23 46 26 3 4 5 % 25 % 19 2 1 Schwilk 20 3.1 % 5.5 % 1.8 2.3 6.3 2 Wellman 21 2 Bluman 4 ARDS 3 1 Warner 22 8 14.5 % 8 57.9 % 6 Nakagawa 23 23.9 %43.2 % 4 34.7 % 48 Kuri 24 85.7 % 3 67.6 %6 55.0 %7 59.1 % 47.5 % 3 2 Moller 25 52 % 18 % 4 3 1458 % WHO 2005 2 27 Circulation Journal Vol. 69, Suppl. IV, 2005 1121

20032004 9 1 11 12 13 2 21 2 21 22 3 31 32 33 4 41 42 43 22 3 31 32 1 33 1122 Circulation Journal Vol. 69, Suppl. IV, 2005

2003 10 9 QOL 11 2004 4 9 26 4 41 42 43 9 Circulation Journal Vol. 69, Suppl. IV, 2005 1123

20032004 1 U.S. Department of Health and Human Services, Public Health Service. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD, 2000 2 2002; 127(7): 1025-1030 3 Silagy C, Lancaster T, Stead, L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004 CD000146 4 1999; p78-79 5 Non-Smokers Rights Association, Canada: Average Retail Cigarette Price and Total Taxes per Pack (US Dollars/Pack of 20), Selected Industrialized Countries, June 17th, 2002 http://www.nsra-adnf.ca 6 TOBACCO FREEJAPAN 2004 7 http://fctc.org/ 8 2004; 68(12): 948-952 9 Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority. Thorax 1998; 53(suppl.5 part 1): s1-19 10 2004 2005; 133(4): 505-517 11 Shafey O, Dolwick S, Guindon GE (eds). Tobacco Control Country Profiles 2003, American Cancer Society, Atlanta, GA, 2003 12 2000 13 2002: p136 14 COPD COPD 1999; p39 15 2002; 1: 218-223 16 DiFranza JR, Savageau JA, Rigotti NA, et al. Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study. Tob Control 2002; 11: 228-235 17 2005; 46: 188-196 18 Moolchan ET, Robinson ML, Ernst M, et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics 2005; 115: e407-414 19 Office of Surgeon General. 2004 Surgeon General s Report: The Health Consequences of Smoking. In Chapter 2, Cancer, Oral cavity and pharyngeal cancer, p.63-116 and Chapter 6, Other effects, Dental diseases, p.732-766, USDHHS, 2004 20 Schwilk B, Bothner U, Schraag S, et al. Perioperative respiratory events in smokers and nonsmokers undergoing general anaesthesia. Acta Anaesthesilo Scand 1997; 41: 348-355 21 Wellman JJ, Smith BA. Respiratory complications of surgery, in Medical Management of the Surgical Patient (2nd ed). Edited by Lubin MF, Walker HK, Smith RB. Butterworth, Boston, 1988; p155-160 22 Warner MA, Offord KP, Warner ME, et al. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989; 64: 609-616 23 Nakagawa M, Tanaka H, Tsukuma H, et al. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest 2001; 120: 705-710 24 Kuri M, Nakagawa M, Tanaka H, et al. Determination of duration of preoperative smoking cessation to improve wound healing after head and neck surgery. Anesthesiology 2005; 102: 892-896 25 Moller AM, Pedersen T, Villebro N, et al. Effect of preoperative smoking intervention on postoperative complications: a randomized clinical trial. Lancet 2002, 359: 114-117 26 Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the smoke: the science base for tobacco harm reduction - executive summary. Tobacco Control 2001; 10: 189-195 1124 Circulation Journal Vol. 69, Suppl. IV, 2005